Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Treosulfan-based conditioning for HCT in nonmalignant inherited disorders
NCT00919503Phase 2Completed
- Sponsor
- Fred Hutchinson Cancer Center
- Start
- Jul 2009
- Primary completion
- Jun 2020
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of treosulfan in Inherited disorder, sponsored by Fred Hutchinson Cancer Center. Started Jul 2009; status: completed.
02
Drugs
treosulfan
03
Conditions
Inherited disorder
Beyond the preview
Go deeper on NCT00919503.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00919503.